BioStem Technologies (OTCMKTS:BSEM) Releases Earnings Results, Beats Expectations By $0.01 EPS

BioStem Technologies (OTCMKTS:BSEM) announced its quarterly earnings results on Tuesday. The company reported 0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of 0.31 by 0.01, Zacks reports. The company had revenue of 82.56 million during the quarter, compared to analysts’ expectations of 78.22 million.

BioStem Technologies Stock Performance

Shares of BSEM opened at 17.41 on Friday. BioStem Technologies has a fifty-two week low of 2.34 and a fifty-two week high of 28.26. The stock has a fifty day moving average of 13.28 and a two-hundred day moving average of 10.64. The company has a market capitalization of $289.35 million, a PE ratio of 34.35 and a beta of -0.36.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.